Multiple Myeloma Life Expectancy

Multiple myeloma life expectancy - Also known as the disease of Rustycage Calera, is a malignant tumor that is generated on the basis of plasma cells. This disease of the blood system are referred to paraproteinemic leucosis. It occurs due to the disruption of b-cells, which begin to be produced by the body in unlimited quantities and create disease. Its difficult to name the disease was due to common location in the bone marrow. Multiple myeloma life expectancy of a negative impact – before the invention of the first medications people lived with this diagnosis a year and a half. But gradually, with the development of science, doctors were able to give the opportunity to live patients this disease up to 5 years.
Multiple Myeloma Life Expectancy

Multiple Myeloma Life Expectancy

We should also talk about the methods and tactics of treatment of diseases:
  • Chemotherapy. The main method of treatment of multiple myeloma. Is the first effective medication. The essence of chemotherapy is that cancer cells absorb all incoming body substances, including harmful be due to the fact they can "slip" hazardous substances and to expect that they will die. In this case, the emphasis is on the fact that the malicious cells will die before the body, which is their carrier. 
  • Symptomatic treatment. This treatment is done with the help of adequate correction of hypercalcemia, orthopaedic, using analgesics along with hemostatic therapy. 
  • Surgical method of treatment. Apply in the case of solitary myeloma or compression of the vital organs of the body. 
  • Radiation therapy. Used to treat those patients who are already weakened — in the case of kidney failure, local bone lesions and resistance of cancer cells to chemotherapy. 
See also: Multiple Myeloma Stages Life Expectancy
Tactics of treatment less – there are only three:
  • The initial therapy. Initiation of treatment depends on the age and concomitant diseases of the patient. If the patient is 65 years of age and no serious concomitant disease, he is prescribed high dose chemotherapy and transplanting stem cells. In other cases, the use of strong medications is not effective, and such a diagnosis only 17 with 100 live more than 2.5 years.
  • Supportive therapy. Applies to those who receive high-dose chemotherapy. During supportive therapy, thalidomide, bortezomib and lenalidomide. Treatment of resistant forms and recurrences. Relapses occur in virtually all patients. Alas, this sad side of the statistics. During this therapy may be a repetition of previously prescribed therapy for which the patient was treated, and the administration of other drugs that are more active. Also used different drugs – if first used lenalidomide, at relapse bortezomib use.
See also: Multiple Myeloma and Kidney Failure Life Expectancy

The Life Expectancy at Different Treatment

Multiple myeloma life expectancy - People who have cancer, interested in how living with myeloma? It all depends on the condition of the body at the time of the disease and the applied treatment. People who have good health, play sports, drink a lot of water, stick to diet and do not have serious pathologies are living longer.

If untreated myeloma — forecast is about 1.5 with 100% fatal outcome. In the treatment of the most modern polychemotherapy, consisting of various drugs (anthracyclines, alkylating tools, corticosteroids, Vinca alkaloids) life time of the 1st patient until death ranges from 3 to 3.5 years. The effectiveness of treatment in different groups varies from 60 to 70%.